5Mogensen CE, Schmitz A, Christensen CK. Comparati-e renal pathophysiology rele-ant to IDDM and NIDDM patients. Diabetes Metab Re-, 1988,4(5) :453 -483.
6Jadad AR, Moore A, Carroll D, et al. Assessing the quality of re- ports of randomized clinical trials : Is blinding necessary. Control Clin TriMs, 1996,17 ( 1 ) : 1 - 12.
7Moher D, Pham B, Jones A, et al. Does quality of reports of repor- ted in meta - analyses. Lancet, 1998,352:609 - 613.
8Kjaergard LL, Villuumsen J, Gluud C. Quality of randomized clin- ical trials affect estimates of inter-ention efficacy (abstract). In: Ⅶ Cochrane Colloquium, 1999.57.
